Objective: To investigate the effect of modified Bazhentang combined with moxa-moxibustion on the tolerance

pain relief and life quality of patients receiving radiotherapy and chemotherapy for advanced cervical cancer. Method: A total of 106 cases of patients with advanced cervical cancer admitted in our hospital from February 2014 to April 2017 were selected and divided into observation group and control group by random number table

with 53 cases in each group. All of the patients were given radiotherapy and chemotherapy. In addition to radiotherapy and chemotherapy

the observation group was also treated with modified Bazhentang combined with moxa-moxibustion. An evaluation on the short-term efficacy of two groups was carried out after one course of treatment. The cellular immune indexes

nutritional indicator

pain visual analogue scale (VAS)

Karnofsky scores (KPS) and incidence of adverse reactions were recorded and compared between the two groups. Result: The overall effective rate of observation group was 86.79%

which was higher than 60.38% of control group (P<0.05). After treatment

the CD3+

CD4+

CD4+/CD8+

NK cells of observation group remarkably increased compared with those before treatment (P<0.05)

but those of control group showed no big difference. What's more

the above index levels of observation group were higher than those of control group at the same time points after treatment (P<0.05). Compared with those before treatment

serum albumin

prealbumin and transferrin levels of observation group after treatment gained an evident increase (P<0.05)

but those of control group showed a big decrease (P<0.05). After treatment

all serum nutritional indicators were better than those of control group (P<0.05). The pain VAS scores of both groups began to rise after 1 week of treatment

but the scores of observation group after 1

2

4 weeks of treatment were much lower than those of control group in the same period (P<0.05). The KBS effective rate of observation group was 84.91%

which was significantly higher than 50.94% of control group (P<0.05). The incidences of aleucocytosis and emesis of observation group respectively were 35.85% and 18.87%

which were much lower than 56.60% and 52.83% of control group (P<0.05). Conclusion: In treatment of advanced cervical cancer

modified Bazhentang combined with moxa-moxibustion can significantly improve the effects of radiotherapy and chemotherapy

enhance the immune function

relieve pain

and improve the patients' chemotherapeutic tolerance of patients and their life quality.